Physician profile
Elvis Wayne Danne
NPI 1144733916
$35,199.35
in general payments reported to CMS, 2019-2025
35 companies · $12K in 2025
The $12K reported for 2025 was more than what 98% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $177 · 2021: $865 · 2022: $12K · 2023: $5,487 · 2024: $4,233 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Consulting Fee: $6,000 · Travel and Lodging: $5,526 · Gift: $32.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,204.44 |
| Consulting Fee | $6,000.00 |
| Travel and Lodging | $5,526.11 |
| Gift | $32.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifenet Health | $8,763.19 | 2024-2025 | Theragenesis Wound Matrix |
| Vilex LLC | $7,065.54 | 2022 | |
| Stryker Corporation | $2,689.53 | 2022-2025 | Prostep, Hoffmann, Prostep Mica |
| Polynovo North America LLC | $2,499.19 | 2023-2025 | Novosorb Btm |
| Integra Lifesciences Corporation | $1,557.92 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Suvon Surgical LLC | $1,541.55 | 2022-2023 | |
| Smith+Nephew, INC. | $1,377.14 | 2020-2023 | Oasis, Regranex, Collagenase Santyl |
| Medline Industries LP | $1,274.61 | 2023-2024 | |
| Prodigy Surgical Distribution, INC. | $1,200.00 | 2022 | |
| Arteriocyte Medical Systems, INC. | $1,085.46 | 2022-2025 | Magellan |
| In2bones USA, LLC | $968.62 | 2022 | |
| Bioventus LLC | $535.34 | 2022-2023 | Nexus |
| Acera Surgical, INC. | $507.83 | 2023-2025 | Restrata Wound Matrix |
| International Life Sciences | $468.72 | 2023 | |
| Arthrex, INC. | $462.48 | 2023 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $442.35 | 2023-2025 | Physio-Stim |
| Linvatec Corporation | $413.11 | 2025 | Biobrace 23mm, Colink Plating System, Hercules Suture Anchor System |
| Treace Medical Concepts, INC. | $298.55 | 2022-2025 | |
| Next Science LLC | $286.20 | 2024-2025 | Xperience, Blastx, Surgx |
| Gramercy Extremity Orthopedics LLC | $267.22 | 2023 | |
| Organogenesis INC. | $232.31 | 2022-2023 | Puraply |
| Extremity Medical | $222.20 | 2021-2023 | Io Fix |
| Avita Medical Americas, LLC | $153.95 | 2023 | Recell |
| Nevro Corp. | $141.43 | 2022 | |
| Abbvie INC. | $133.83 | 2023-2025 | Dalvance |
| Solventum Corporation | $127.11 | 2024 | Activ.A.C., Prevena, V.A.C. Veraflo Cleanse Choice |
| Royal Biologics, INC. | $122.82 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $91.24 | 2023 | |
| Novastep INC. | $54.59 | 2023 | Peca Bunion Correction System |
| Baxter Healthcare | $54.24 | 2022 | |
| Kerecis Limited | $47.59 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Medtronic, INC. | $47.10 | 2024 | Intellis Adaptivestim |
| Kci USA, INC. | $30.87 | 2022 | |
| Mimedx Group, INC. | $22.32 | 2024 | |
| Abbott Laboratories | $13.20 | 2023 | Diamondback Peripheral |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elvis Danne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.